Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 3 Subgroup analysis of dual contraceptive utilization among HIV positive women in Ethiopia

From: Dual contraceptive utilization and determinant factors among HIV positive women in Ethiopia: a systematic review and meta-analysis, 2020

Variables

Characteristics

Included studies

Number of study participants

Prevalence (95% CI)

I2(%), P-value

Region

Amhara

5

2245

22.72 (16.66–28.78)

98.3, < 0.001

Oromia

6

2299

29.96 (17.98–41.93)

99.6, < 0.001

A. A

1

1418

18.00 (16.32–19.63)

Tigray

4

2291

24.11 (11.79–36.42)

99.5, < 0.001

Benishangul

1

403

40.90 (38.75–43.05)

SNNP

2

512

24.04 (15.71–32.37)

97.5, < 0.001

Sample size

≤400

10

3285

25.58 (18.38–32.77)

99.4, < 0.001

> 400

9

,5883

26.77 (19.60–33.94)

99.3, < 0.001

Year of publication

2013–2015

11

5763

23.91 (19.43–28.40)

98.5, < 0.001

2016–2018

2

639

20.84 (10.74–30.93)

98.5, < 0.001

2019–2020

6

2766

31.99 (18.31–45.67)

99.7, < 0.001

Overall

 

19

9168

26.14 (21.20–31.08)

99.3, < 0.001